162 related articles for article (PubMed ID: 30543692)
1. The multi-country PROMOTE HIV antiretroviral treatment observational cohort in Sub-Saharan Africa: Objectives, design, and baseline findings.
Taha TE; Yende-Zuma N; Aizire J; Chipato T; Wambuzi Ogwang L; Makanani B; Chinula L; Nyati MM; Hanley S; Brummel SS; Fowler MG
PLoS One; 2018; 13(12):e0208805. PubMed ID: 30543692
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.
Taha TE; Yende-Zuma N; Brummel SS; Stranix-Chibanda L; Wambuzi Ogwang L; Dadabhai S; Chinula L; Nyati MM; Hanley S; Makanani B; Chipato T; Atuhaire P; Aizire J; Fowler MG
Lancet HIV; 2022 Jun; 9(6):e394-e403. PubMed ID: 35489365
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
[TBL] [Abstract][Full Text] [Related]
4. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
Omonaiye O; Kusljic S; Nicholson P; Manias E
BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
[TBL] [Abstract][Full Text] [Related]
6. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Impact of inter-partner HIV disclosure patterns in Malawi's PMTCT program: A mixed-method study.
van Lettow M; Cataldo F; Landes M; Kasende F; Nkhoma P; van Oosterhout JJ; Kim E; Schouten E; Nkhoma E; Nyirenda R; Tippett Barr BA
PLoS One; 2019; 14(7):e0219967. PubMed ID: 31348782
[TBL] [Abstract][Full Text] [Related]
9. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda.
Aizire J; Sikorskii A; Ogwang LW; Kawalazira R; Mutebe A; Familiar-Lopez I; Mallewa M; Taha T; Boivin MJ; Fowler MG;
AIDS; 2020 Feb; 34(2):215-225. PubMed ID: 31634154
[TBL] [Abstract][Full Text] [Related]
10. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).
Dadabhai S; Gadama L; Chamanga R; Kawalazira R; Katumbi C; Makanani B; Dula D; Hua N; Lau B; Mallewa M; Taha TE
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):7-14. PubMed ID: 30272628
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
[TBL] [Abstract][Full Text] [Related]
13. Breastfeeding Among Women Living With HIV in the Era of Lifelong ART: An Observational Multicountry Study in Eastern and Southern Africa.
Taha TE; Bandala-Jacques A; Yende-Zuma N; Violari A; Stranix-Chibanda L; Atuhaire P; Hanley S; Gadama L; Chinula L; Dadabhai S; Aizire J; Brummel SS; Fowler MG
J Acquir Immune Defic Syndr; 2024 Jan; 95(1):10-17. PubMed ID: 37732877
[TBL] [Abstract][Full Text] [Related]
14. Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.
Giuliano M; Andreotti M; Liotta G; Jere H; Sagno JB; Maulidi M; Mancinelli S; Buonomo E; Scarcella P; Pirillo MF; Amici R; Ceffa S; Vella S; Palombi L; Marazzi MC
PLoS One; 2013; 8(7):e68950. PubMed ID: 23894379
[TBL] [Abstract][Full Text] [Related]
15. Uptake of care and treatment amongst a national cohort of HIV positive infants diagnosed at primary care level, South Africa.
Mathivha E; Olorunju S; Jackson D; Dinh TH; du Plessis N; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):790. PubMed ID: 31526376
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi.
van Lettow M; Tweya H; Rosenberg NE; Trapence C; Kayoyo V; Kasende F; Kaunda B; Hosseinipour MC; Eliya M; Cataldo F; Gugsa S; Phiri S;
Reprod Health; 2017 Jul; 14(1):82. PubMed ID: 28693525
[TBL] [Abstract][Full Text] [Related]
17. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
[TBL] [Abstract][Full Text] [Related]
18. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
[TBL] [Abstract][Full Text] [Related]
19. Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.
Santosa WB; Staines-Urias E; Tshivuila-Matala COO; Norris SA; Hemelaar J
AIDS; 2019 Aug; 33(10):1623-1633. PubMed ID: 30932959
[TBL] [Abstract][Full Text] [Related]
20. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
